natgillin/translations-raw huggingface dataset:
GANFORT single-dose may cause your eyelashes to darken and grow, and cause the skin around the eye to darken too. 
Jednodozni GANFORT može prouzročiti tamnjenje i rast trepavica te tamnjenje kože oko oka.
Summary of the safety profile 
GANFORT Sažetak sigurnosnog profila
Like other topically applied ophthalmic drugs, GANFORT (bimatoprost/timolol) is absorbed into the systemic circulation. 
Kao i kod ostalih topikalno primijenjenih oftalmoloških lijekova, GANFORT (bimatoprost/timolol) se apsorbira u sistemsku cirkulaciju.
Benzalkonium chloride may cause eye irritation and is also known to discolour soft contact lenses. 
Benzalkonijev klorid može nadražiti oči i poznato je da mijenja boju mekih kontaktnih leća.
Do not use GANFORT after the expiry date which is stated on the bottle label and the carton after EXP. 
Ovaj lijek se ne smije upotrijebiti nakon isteka roka valjanosti navedenog na naljepnici bočice i kutiji iza oznake „Rok valjanosti”.
A topical overdose with GANFORT is not likely to occur or to be associated with toxicity. 
Topikalno predoziranje GANFORT-om nije vjerojatno, kao ni njegova povezanost s toksičnošću.
Patients with cardiovascular diseases (e.g. coronary heart disease, Prinzmetal's angina and cardiac failure) and receiving hypotension therapy with beta-blockers should be critically assessed and therapy with other active substances should be considered. 
Bolesnike koji primaju beta-blokatore za liječenje kardiovaskularnih bolesti (npr. koronarne bolesti srca, Prinzmetalove angine i srčanog zatajenja) te hipotenzije, potrebno je kritički procijeniti i razmotriti kod njih liječenje drugim djelatnim tvarima.
Therefore monitoring is required with frequent or prolonged use of GANFORT in dry eye patients or where the cornea is compromised. 
Stoga je potrebno pratiti bolesnike u slučaju učestalog ili produljenog korištenja GANFORT-a u bolesnika sa suhim očima ili kompromitiranom rožnicom.
Repeated dose ocular toxicity studies on GANFORT showed no special hazard for humans. 
Ispitivanja okularne toksičnosti ponovljenih doza GANFORT-a ne ukazuju na poseban rizik za ljude.
The adverse reactions reported in the clinical study using GANFORT single-dose were limited to those earlier reported for either GANFORT (multi-dose formulation) or for the single active substances bimatoprost or timolol. 
Nuspojave prijavljene u kliničkom ispitivanju s GANFORT-om ograničene su na prethodno prijavljene nuspojave na GANFORT (višedozni pripravak) ili na pojedinačne djelatne tvari bimatoprost ili timolol.
How to store GANFORT 
Kako primjenjivati GANFORT
A topical overdose with GANFORT single-dose is not likely to occur or to be associated with toxicity. 
Topikalno predoziranje jednodoznim GANFORT-om nije vjerojatno, kao ni njegova povezanost s toksičnošću.
Turn the single-dose container upside down and squeeze it to release 1 drop into the affected eye(s). 
Okrenite jednodozni spremnik prema dolje i stisnite kako bi se otpustila jedna kap u oko (oči) koje treba liječiti.
Each pouch contains 10 single-dose containers. 
Jedna vrećica sadrži 10 jednodoznih spremnika.
The majority of adverse reactions reported with GANFORT single-dose were ocular, mild in severity and none were serious. 
Većina nuspojava prijavljenih u kliničkim ispitivanjima s jednodoznim GANFORT-om odnosile su se na oko, bile su blagog oblika i nijedna od njih nije bila ozbiljna.
White opaque low-density polyethylene bottles with polystyrene screw cap. Each bottle has a fill volume of 3 ml. 
Bijele, neprozirne, plastične bočice od polietilena niske gustoće s polistirenskim zatvaračem s navojem.
Eye disorders decreased corneal sensitivity1, diplopia1, ptosis1, choroidal detachment following filtration surgery (see section 4.4)1, keratitis1, blepharospasm2, retinal haemorrhage2, uveitis2, 
Poremećaji oka smanjena osjetljivost rožnice1, diplopija1, ptoza1, ablacija žilnice nakon filtracijske operacije (vidjeti dio 4.4) 1, keratitis1, blefarospazam2, retinalno krvarenje2, uveitis2,
GANFORT may cause your eyelashes to darken and grow, and cause the skin around the eyelid to darken too. 
GANFORT može prouzročiti tamnjenje i rast trepavica te tamnjenje kože oko vjeđe.
- If you have any further questions, please ask your doctor, pharmacist, or nurse. 
- Ako imate dodatnih pitanja, obratite se liječniku, ljekarniku ili medicinskoj sestri.
Due to the beta-adrenergic component, timolol, the same types of cardiovascular, pulmonary and other adverse reactions (ADRs) as seen with systemic beta-blockers may occur. 
Zbog beta-adrenergičke komponente u obliku timolola mogu se pojaviti iste vrste kardiovaskularnih, plućnih i ostalih nuspojava opaženih kod sistemskih beta blokatora.
Ganfort contains a preservative called benzalkonium chloride. 
GANFORT sadrži benzalkonijev klorid kao konzervans.
GANFORT single-dose has a rapid onset of action. 
Jednodozni GANFORT djeluje vrlo brzo nakon primjene.
Cardiac disorder atrioventricular block1, cardiac arrest1, arrhythmia1, cardiac failure1, congestive heart failure1, chest pain1, palpitations1, oedema1 
Srčani poremećaji atrioventrikularni blok1, srčani zastoj1, aritmija1, srčano zatajenje1, kongestivno srčano zatajenje1, bol u prsištu1, palpitacije1, edem1
If you stop using GANFORT single-dose 
Ako prestanete primjenjivati jednodozni GANFORT
GANFORT single-dose has not been studied in patients with inflammatory ocular conditions, neovascular, inflammatory, angle-closure, congenital or narrow-angle glaucoma. 
Jednodozni GANFORT nije ispitan kod bolesnika s upalnim stanjima oka, neovaskularnim, upalnim, kongenitalnim glaukomom te glaukomom zatvorenog ili uskog kuta.
Uncommon iritis2, conjunctival oedema2, eyelid pain2, abnormal sensation in the eye1, asthenopia, trichiasis2, iris hyperpigmentation2, deepening of eyelid sulcus, eyelid retraction2, eyelash discolouration (darkening)1. 
Manje često iritis2, edem konjunktive2, bol vjeđa2, abnormalni osjećaj u oku1, astenopija, trihijaza2, hiperpigmentacija šarenice2, produbljenje palpebralnog sulkusa, retrakcija vjeđe2, promjena boja trepavica (tamnjenje) 1.
Keep single-dose containers in the pouch in order to protect from light and moisture. 
Jednodozne spremnike držite u vrećici kako biste ih zaštitili od svjetlosti i vlage.
There is a potential for additive effects resulting in hypotension, and/or marked bradycardia when ophthalmic beta-blockers solution is administered concomitantly with oral calcium channel blockers, guanethidine, beta-adrenergic blocking agents, parasympathomimetics, anti-arrhythmics (including amiodarone) and digitalis glycosides. 
Postoji mogućnost aditivnih učinaka koji rezultiraju hipotenzijom, i/ili izrazitom bradikardijom kada se oftalmološki beta-blokator u otopini istovremeno primjenjuje s peroralnim blokatorima kalcijevih kanala, gvanetidinom, beta-adrenergičkim blokatorima, parasimpatomimeticima, antiaritmicima
GANFORT single-dose has not been studied in patients with hepatic or renal impairment. 
Jednodozni GANFORT nije ispitivan u bolesnika s jetrenim ili bubrežnim oštećenjima.
GANFORT has not been studied in patients with hepatic or renal impairment. 
GANFORT nije ispitivan u bolesnika s jetrenim ili bubrežnim oštećenjima.
If you forget to use GANFORT single-dose 
Ako ste zaboravili primijeniti jednodozni GANFORT
Keep the singledose containers in the pouch and place the pouch back in carton in order to protect against light and moisture. 
Jednodozne spremnike držite u vrećici, a vrećicu stavite natrag u kutiju kako biste ih zaštitili od svjetlosti i vlage.
Colourless to slightly yellow solution. 
Bezbojna do blago žućkasta otopina.
Eye drops, solution, 3 x 3 ml 
Kapi za oko, otopina, 3 x 3 ml
Fertility There are no data on the effects of GANFORT single-dose on human fertility. 
Nema podataka o djelovanju jednodoznog GANFORT-a na ljudsku plodnost.
Absorption of timolol may cause similar undesirable effects as seen with systemic beta-blocking agents. 
Apsorpcija timolola može prouzročiti slične nuspojave kao i kod sistemskih beta-blokatora.
GANFORT has not been studied in patients with inflammatory ocular conditions, neovascular, inflammatory, angle-closure glaucoma, congenital glaucoma or narrow-angle glaucoma. 
GANFORT nije ispitan kod bolesnika s upalnim stanjima oka, neovaskularnim, upalnim, kongenitalnim glaukomom te glaukomom zatvorenog ili uskog kuta.
Adverse reactions reported in phosphate containing eye drops 
Nuspojave prijavljene pri primjeni kapi za oko koje sadrže fosfate
Once the container is removed from the pouch use within 7 days. 
Nakon vađenja spremnika iz vrećice, iskoristiti unutar 7 dana.
Affecting the eye cystoid macular oedema (swelling of the retina within the eye leading to worsening vision), eye swelling, blurred vision. 
Nuspojave kod kojih je učestalost nepoznata Zahvaćaju oko cistoidni makularni edem (oticanje mrežnice u oku što dovodi do pogoršanja vida), oticanje oka,
Clear, single-dose low density polyethylene (LDPE) containers with a twist-off tab. 
Prozirni jednodozni spremnici od polietilena niske gustoće (LDPE) sa zatvaračem na navoj.
5 How to store GANFORT Contents of the pack and other information 
Sadržaj pakiranja i druge informacije
Tel: +386 (0) 590 848 40 
Ewopharma d.o.o. Tel: +386 (0) 590 848 40
PARTICULARS TO APPEAR ON THE OUTER PACKAGING CARTON FOR POUCH CONTAINING STRIP OF 5 SINGLE-DOSE CONTAINERS 
PODACI KOJI SE MORAJU NALAZITI NA VANJSKOM PAKIRANJU KUTIJA ZA VREĆICU KOJA SADRŽI STRIP S 5 JEDNODOZNIH SPREMNIKA
Eye drops, solution, 3 ml 
Kapi za oko, otopina, 3 ml
Not known cystoid macular oedema2, eye swelling, vision blurred2, 
Nepoznato cistoidni makularni edem2, oticanje oka, zamućen vid2,
• The other ingredients are benzalkonium chloride (a preservative), sodium chloride, sodium phosphate dibasic heptahydrate, citric acid monohydrate and purified water. 
• Drugi sastojci su benzalkonijev klorid (kao konzervans), natrijev klorid, natrijev hidrogenfosfat heptahidrat, citratna kiselina hidrat i pročišćena voda.
This may cause similar side effects as seen with ”intravenous” and /or “oral” beta-blocking agents. 
To može prouzročiti slične nuspojave kao i kod beta-blokatora koji se primjenjuju u venu i/ili kroz usta.
Remove contact lenses before use. 
Prije primjene izvaditi kontaktne leće.
No new adverse reactions specific for GANFORT have been observed in clinical studies. 
U kliničkim ispitivanjima nisu zabilježene nove nuspojave specifične za GANFORT.
GANFORT may cause blurred vision in some patients. 
Kod nekih bolesnika GANFORT može prouzročiti zamagljen vid.
PARTICULARS TO APPEAR ON THE OUTER PACKAGING POUCH CONTAINING STRIP OF 5 SINGLE-DOSE CONTAINERS 
PODACI KOJI SE MORAJU NALAZITI NA VANJSKOM PAKIRANJU VREĆICA KOJA SADRŽI STRIP S 5 JEDNODOZNIH SPREMNIKA
Benzalkonium chloride, sodium chloride, sodium phosphate dibasic heptahydrate, citric acid monohydrate, hydrochloric acid or sodium hydroxide (to adjust pH) and purified water. 
Benzalkonijev klorid, natrijev klorid, natrijev hidrogenfosfat heptahidrat, citratna kiselina hidrat, kloridna kiselina ili natrijev hidroksid (za podešavanje pH) i pročišćena voda.
Sodium chloride, sodium phosphate dibasic heptahydrate, citric acid monohydrate, hydrochloric acid or sodium hydroxide (to adjust pH) and purified water. 
Natrijev klorid, natrijev hidrogenfosfat heptahidrat, citratna kiselina hidrat, kloridna kiselina ili natrijev hidroksid (za podešavanje pH) i pročišćena voda.
Cases of corneal calcification have been reported very rarely in association with the use of phosphate containing eye drops in some patients with significantly damaged corneas. 
U nekih bolesnika sa značajno oštećenom rožnicom prijavljeni su vrlo rijetki slučajevi kalcifikacije rožnice povezani s primjenom kapi za oko koje sadrže fosfate.
Respiratory disorders 
Poremećaji jetre
Once the single-dose container is removed from the pouch use within 7 days. 
Nakon vađenja jednodoznog spremnika iz vrećice, iskoristite unutar 7 dana.
Keep GANFORT single-dose out of the sight and reach of children. 
Kako čuvati jednodozni GANFORT Jednodozni GANFORT čuvajte izvan pogleda i dohvata djece.
Like other topically applied ophthalmic medicinal products, the active substances (timolol/ bimatoprost) in GANFORT may be absorbed systemically. 
Kao i kod ostalih topikalno primijenjenih oftalmoloških lijekova, djelatne tvari (timolol/bimatoprost) sadržane u kapima GANFORT mogu se sistemski apsorbirati.
• The other ingredients are sodium chloride, sodium phosphate dibasic heptahydrate, citric acid monohydrate and purified water. 
• Drugi sastojci su natrijev klorid, natrijev hidrogenfosfat heptahidrat, citratna kiselina hidrat i pročišćena voda.
Neither nevi nor freckles of the iris appear to be affected by treatment. 
Čini se da liječenje ne utječe na nevuse i pjege šarenice.
Recommended dosage in adults (including older people) The recommended dose is one drop of GANFORT single-dose in the affected eye(s) once daily, administered either in the morning or in the evening. 
Preporučena doza je jedna kap jednodoznog GANFORT-a jedanput dnevno u zahvaćeno oko (oči), ukapana ujutro ili uvečer.
How to store GANFORT single-dose 
Kako primjenjivati jednodozni GANFORT
Do not use GANFORT single-dose if you are breast-feeding. 
Nemojte primjenjivati jednodozni GANFORT ako dojite.
All containers should be kept in the pouch and carton to protect from light and moisture and discarded 10 days after first opening the pouch. 
Spremnike držite u vrećici, a vrećicu vratite natrag u kutiju kako biste ih zaštitili od svjetlosti i vlage i bacite 10 dana od prvog otvaranja vrećice.
Like other topically applied ophthalmic medicinal products, the active substances (timolol/ bimatoprost) in GANFORT single-dose may be absorbed systemically. 
Kao i kod ostalih topikalno primijenjenih oftalmoloških lijekova, djelatne tvari (timolol/bimatoprost) sadržane u kapima jednodoznog GANFORT-a mogu se sistemski apsorbirati.
GANFORT single-dose may cause blurred vision in some patients. 
Kod nekih bolesnika jednodozni GANFORT može prouzročiti zamagljen vid.
Therefore, GANFORT single-dose should be used with caution in aphakic patients, in pseudophakic patients with a torn posterior lens capsule, or in patients with known risk factors for macular oedema (e.g. intraocular surgery, retinal vein occlusions, ocular inflammatory disease and diabetic retinopathy). 
(višedozni pripravak) Stoga jednodozni GANFORT treba koristiti s oprezom kod bolesnika s afakijom, u bolesnika s pseudoafakijom s pokidanom stražnjom kapsulom leće, ili kod bolesnika s poznatim faktorom rizika za nastanak edema makule (npr. nakon intraokularnog kirurškog zahvata,
Rhinitis2 
Često rinitis2
Gastrointestinal disorders nausea1,2, diarrhoea1, dyspepsia1, dry mouth1, abdominal pain1, vomiting1 
Poremećaji probavnog sustava mučnina1,2, dijareja1, dispepsija1, suhoća usta1, bol u abdomenu1, povraćanje1
Respiratory, thoracic and mediastinal disorders Asthma exacerbation2, COPD exacerbation2, cough1 
Poremećaji dišnog sustava, prsišta i sredoprsja egzacerbacija astme2, egzacerbacija KOPB-a2,
Recommended dosage in adults (including older people) The recommended dose is one drop of GANFORT in the affected eye(s) once daily, administered either in the morning or in the evening. 
Preporučena doza je jedna kap GANFORT-a jedanput dnevno u zahvaćeno oko (oči), ukapana ujutro ili uvečer.
No new adverse reactions specific for GANFORT single-dose have been observed in clinical studies. 
U kliničkim ispitivanjima nisu zabilježene nove nuspojave specifične za jednodozni GANFORT.
The change may be more noticeable if you are only treating one eye. GANFORT singledose may cause hair growth when in contact with the skin surface. 
Primjena jednodoznog GANFORT-a može uzrokovati rast dlake ako dođe u kontakt s površinom kože.
Eye drops, solution 90 x 0.4 ml 
Kapi za oko, otopina 90 x 0,4 ml
Affecting the eye abnormal sensation in the eye, iris inflammation, swollen conjunctiva (see-through layer of the eye), painful eyelids, tired eyes, in-growing eyelashes, darkening of iris colour, eyes appear sunken, eyelid has moved away from the surface of the eye, darkening of eyelashes. 
Abnormalni osjećaj u oku, upala šarenice, otečena očna spojnica (prozirna sluznica oka), bolne vjeđe, umorne oči, rast trepavica prema unutra, tamnjenje šarenice, oči koje se doimaju upalo, odvajanje vjeđe od površine oka, tamnjenje trepavica.
Eye drops, solution 5 x 0.4 ml 
Kapi za oko, otopina 5 x 0,4 ml
Do not use GANFORT single-dose after the expiry date which is stated on the single-dose container and the carton. 
Jednodozni GANFORT se ne smije upotrijebiti nakon isteka roka valjanosti navedenog na jednodoznom spremniku i kutiji iza oznake „EXP/Rok valjanosti”.
PARTICULARS TO APPEAR ON THE OUTER PACKAGING CARTON CONTAINING THREE BOTTLES 
KUTIJA KOJA SADRŽI TRI BOČICE
Common blepharal pigmentation2, hirsutism2, skin hyperpigmentation (periocular). 
trihijaza2, hiperpigmentacija šarenice2, produbljenje palpebralnog sulkusa,
Eye drops, solution 30 x 0.4 ml 
Kapi za oko, otopina 30 x 0,4 ml
Not known 
Nepoznato umor
One ml of solution contains 0.3 mg bimatoprost and 5 mg timolol (as 6.8 mg of timolol maleate). 
1 ml otopine sadrži 0,3 mg bimatoprosta i 5 mg timolola (u obliku 6,8 mg timololmaleata).
One ml of solution contains 0.3 mg bimatoprost and 5 mg timolol (as 6.8 mg of timolol maleate) 
1 ml otopine sadrži 0,3 mg bimatoprosta i 5 mg timolola (u obliku 6,8 mg timololmaleata)
Package leaflet: Information for the user GANFORT 0.3 mg/ml + 5 mg/ml eye drops, solution, in single-dose container 
Uputa o lijeku: Informacije za korisnika GANFORT 0,3 mg/ml + 5 mg/ml kapi za oko, otopina, u jednodoznom spremniku bimatoprost/timolol
Each pack contains either 1 or 3 plastic bottles each with a screw-cap. Each bottle is about half full and contains 3 millilitres of solution. 
Jedno pakiranje sadrži 1 ili 3 plastične bočice sa zatvaračem s navojem.
Timolol lowers IOP by reducing aqueous humour formation. 
Timolol snižava intraokularni tlak smanjivanjem stvaranja očne vodice.
Choroidal detachment has been reported with administration of aqueous suppressant therapy (e.g. timolol, acetazolamide) after filtration procedures. 
Ablacija žilnice prijavljena je kod primjene supresivne terapije očne vodice (npr. timolol,
2017;26(9):e214-e216, four strong cases of hallucinations with ophthalmic timolol (single-substance) were reported, all in elderly patients with coexisting CNS pathology. 
zabilježena su četiri pouzdana slučaja halucinacija uslijed uzimanja timolola za oftalmološku primjenu (kao pojedinačne tvari), sva četiri u bolesnika starije životne dobi s postojećom patologijom SŽS-a.
Skin and subcutaneous tissue disorders psoriasiform rash1 or exacerbation of psoriasis1, skin rash1 Musculoskeletal and connective tissue disorders myalgia1 Reproductive system and breast disorders sexual dysfunction1, decreased libido1 
Poremećaji kože i potkožnog tkiva osip koji nalikuje psorijazi1 ili egzacerbacija psorijaze1, osip kože1
Package leaflet: Information for the user GANFORT 0.3 mg/ml + 5 mg/ml eye drops, solution 
Uputa o lijeku: Informacije za korisnika GANFORT 0,3 mg/ml + 5 mg/ml kapi za oko, otopina bimatoprost/timolol
Bimatoprost is the major circulating species in the blood once it reaches the systemic circulation following ocular dosing. 
Nakon primjene u oko, kada dostigne sistemsku cirkulaciju, bimatoprost je glavna tvar koja cirkulira u tijelu.
Hold the single-dose container upright (with the cap pointing upwards) and twist off the cap. Gently pull down the lower eyelid to form a pocket. 
Pridržavajte jednodozni spremnik uspravno (sa zatvaračem okrenutim prema gore) i odvrnite zatvarač.
Nervous system disorders 
Poremećaji dišnog sustava
PARTICULARS TO APPEAR ON THE OUTER PACKAGING CARTON CONTAINING 90 SINGLE-DOSE CONTAINERS (PROVIDED IN 9 POUCHES, EACH CONTAINING 10 SINGLE-DOSE CONTAINERS) 
KUTIJA KOJA SADRŽI 90 JEDNODOZNIH SPREMNIKA (ISPORUČENIH
GANFORT single-dose should not be used by breast-feeding women. 
Jednodozni GANFORT se ne smije primjenjivati tijekom dojenja.
2 years. 
godine liječenja.
GANFORT contains two different active substances (bimatoprost and timolol) that both reduce pressure in the eye. Bimatoprost belongs to a group of medicines called prostamides, a prostaglandin analogue. 
GANFORT sadrži dvije različite djelatne tvari (bimatoprost i timolol), obje snižavaju očni tlak.
Do not use GANFORT if you are breast-feeding. 
Nemojte primjenjivati GANFORT ako dojite.
GANFORT 0.3 mg/ml + 5 mg/ml eye drops, solution, in single-dose container. 
GANFORT 0,3 mg/ml + 5 mg/ml kapi za oko, otopina, u jednodoznom spremniku.
Bimatoprost/timolol 
Dojenje Timolol
GANFORT 0.3 mg/ml + 5 mg/ml eye drops, solution 
GANFORT 0,3 mg/ml + 5 mg/ml kapi za oko, otopina
Common punctuate keratitis, corneal erosion2, burning sensation2, conjunctival irritation1, eye pruritus, stinging sensation in the eye2, foreign body sensation, dry eye, erythema of eyelid, eye pain, photophobia, eye discharge2, visual disturbance2, eyelid pruritus, visual acuity worsened2, blepharitis2, eyelid oedema, eye irritation, lacrimation increased, growth of eyelashes. 
svrbež oka, osjećaj bockanja u oku2, osjećaj stranog tijela, suho oko, eritem vjeđe, bol u oku, fotofobija, iscjedak iz oka2, smetnje vida2, svrbež vjeđe,
These may affect more than 1 user in 10 Affecting the eye redness. 
Mogu se javiti kod više od 1 na 10 korisnika
Common 
Jednodozni
GANFORT 0.3 mg /ml + 5 mg/ml eye drops, solution bimatoprost/timolol 
GANFORT 0,3 mg/ml + 5 mg/ml kapi za oko, otopina bimatoprost/timolol
Potentiated systemic beta-blockade (e.g. decreased heart rate, depression) has been reported during combined treatment with CYP2D6 inhibitors (e.g. quinidine, fluoxetine, paroxetine) and timolol. 
pri istodobnoj primjeni inhibitora CYP2D6 (npr. kinidin, fluoksetin, paroksetin)i timolola.
GANFORT single-dose contains two different active substances (bimatoprost and timolol) that both reduce pressure in the eye. Bimatoprost belongs to a group of medicines called prostamides, a prostaglandin analogue. 
Jednodozni GANFORT sadrži dvije različite djelatne tvari (bimatoprost i timolol), obje snižavaju očni tlak.
The following side effects may be seen with GANFORT (single-dose and/or multi-dose): 
Pri primjeni GANFORT-a (u obliku jednodoznog i/ili u obliku višedoznog pripravka), mogu se pojaviti sljedeće nuspojave:
Before you use this medicine, tell your doctor if you have now or have had in the past - coronary heart disease (symptoms can include chest pain or tightness, breathlessness or choking), heart failure, low blood pressure, 
Obavijestite svog liječnika ako primjenjujete ili namjeravate primijeniti lijekove za snižavanje krvnog tlaka, lijekove za srce,
Respiratory, thoracic and mediastinal disorders 
- dišnih problema, astme ili kronične opstruktivne bolesti pluća
Vascular disorders 
Ablacija žilnice
- if you are allergic to bimatoprost, timolol, beta-blockers or any of the other ingredients of GANFORT (listed in section 6) - if you have now or have had in past respiratory problems such as asthma, severe chronic obstructive bronchitis (severe lung disease which may cause wheeziness, difficulty in breathing and/ or long-standing cough) - if you have heart problems such as low heart rate, heart block, or heart failure 
(naveden u dijelu 6.) - ako trenutno bolujete ili ste u prošlosti bolovali od respiratornih problema poput astme, teškog kroničnog opstruktivnog bronhitisa (teške plućne bolesti koja može prouzročiti piskanje,
GANFORT should not be used by breast-feeding women. 
GANFORT se ne smije primjenjivati tijekom dojenja.
- coronary heart disease (symptoms can include chest pain or tightness, breathlessness or choking), 
- koronarne bolesti srca (simptomi mogu uključivati bol ili stezanje u prsnom košu, nedostatak zraka ili gušenje), srčanog zatajenja, niskog krvnog tlaka, - poremećaja otkucaja srca kao što su spori otkucaji srca,
The change may be more noticeable if you are only treating one eye. GANFORT may cause hair growth when in contact with the skin surface. 
Promjena može biti uočljivija ako liječite samo jedno oko.
Bradycardia 
Nepoznato bradikardija
GANFORT 0.3 mg/ml + 5 mg/ml eye drops, solution, in single-dose container bimatoprost/timolol 
GANFORT 0,3 mg/ml + 5 mg/ml kapi za oko, otopina, u jednodoznom spremniku bimatoprost/timolol